SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effe (Q68200767)
scientific article published on 01 April 1992
Language:
(P31) (Q13442814)
(P304) 199-211
(P407) (Q1860)
(P433) 2
(P478) 5
(P577) Wednesday, April 1, 1992
(P921) (Q101929)
(P953) https://api.elsevier.com/content/article/PII:089684119290200A?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:089684119290200A?httpAccept=text/plain
(P1433) (Q15716783)
(P1476) "SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effects in clinical, functional and histological studies" (language: en)
"SRI 62–834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effects in clinical, functional and histological studies" (language: en)
(P2093) D. Chabannes
B. Ryffel
J. F. Borel
other details
description scientific article published on 01 April 1992

External Links